Disney Has Its CEO

4 Feb 2026 · 18 min · 6 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Podcast Episode Summary: Disney Has Its CEO

Episode Overview Podcast Title: Motley Fool Money Episode Title: Disney Has Its CEO Release Date: [Insert Date] Hosts: Travis Hoium Guests: Lou Whiteman, Rachel Warren Engineers: Dan Boyd, Kristi Waterworth

The episode discusses the recent appointment of Josh D’Amaro as the new CEO of Disney, succeeding Bob Iger. The conversation also covers Iger’s legacy, Chipotle's latest earnings report, and the competitive landscape of GLP-1 medications in the pharmaceutical industry.

---

Key Topics Discussed

Disney's New Leadership

  • Appointment of Josh D’Amaro:
  • Takes over from Bob Iger on March 18.
  • Dana Walden promoted to Chief Creative Officer.
  • Bob Iger's Legacy:
  • Two distinct tenures: one focused on aggressive acquisitions (Pixar, Marvel, Lucasfilm) and the second on stabilizing Disney amidst various challenges.
  • Iger’s return led to significant cost-cutting measures and a turnaround in Disney's streaming profitability.
  • The stock market's perception of Iger's leadership has been mixed, with concerns over the declining stock price during his second term.
  • Future Direction Under D’Amaro:
  • D’Amaro's background in parks could influence Disney’s future, particularly regarding the core business segments.
  • Discussion about potential media spinoffs and the future of ESPN.
  • Predictions about a more streamlined Disney and potential separation of media assets.

Chipotle's Earnings Overview

  • Declining Results:
  • Chipotle reported a 3.2% drop in transactions in Q4.
  • Rising costs (beef, avocado, labor) impacting margins, which fell to 14.1%.
  • Changing Consumer Behavior:
  • Younger demographics (ages 25-35) are pulling back on discretionary spending.
  • Shift towards sit-down dining experiences, with some fast-casual chains struggling.
  • Growth Strategy:
  • Despite challenges, Chipotle continues to expand, planning to open 370 new restaurants in 2026.
  • Focus on new menu items and pricing strategies to attract cost-conscious consumers.

The GLP-1 Pharmaceutical Landscape

  • Key Players:
  • Novo Nordisk and Eli Lilly are the main companies involved in GLP-1 medications.
  • Market Dynamics:
  • Novo Nordisk faces challenges with declining sales projections and patent expirations, leading to a potential downturn.
  • Eli Lilly is experiencing growth with expected revenue increases and new product launches.
  • Competition and Future Outlook:
  • The episode discusses the competitive pressures in the GLP-1 market and the implications for profitability.
  • Risks associated with new entrants and existing competition impacting market share.

---

Key Takeaways

  • Bob Iger's legacy at Disney is multifaceted, with significant achievements overshadowed by current stock performance and company challenges.
  • Josh D’Amaro’s leadership will be crucial in navigating Disney's future, balancing between its core businesses and potential media spinoffs.
  • Chipotle is facing headwinds from changing consumer preferences, though it remains committed to expansion.
  • The GLP-1 market is becoming increasingly competitive, presenting both challenges and opportunities for companies like Novo Nordisk and Eli Lilly.

---

Conclusion The episode provides insight into significant leadership changes at Disney, challenges facing Chipotle, and the evolving pharmaceutical landscape regarding GLP-1 medications. Investors and stakeholders in the respective companies should monitor these developments closely as they navigate through changing market conditions.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Reflecting on Bob Iger's Tenure

0:45 to 2:12

Analysis of Bob Iger's impact on Disney over two decades and his recent departure.

“The most recent tenure, he turned streaming around.”

The Challenges and Future of Disney

2:12 to 4:36

Discussion on the challenges facing Disney's new CEO and potential future directions.

“What is different this time is they apparently had over 100 people on their radar for this job.”

Chipotle's Quarter Results

4:36 to 7:17

Examination of Chipotle's recent performance and consumer spending trends.

“And presumably, Probably that might help the company to avoid some of the mistakes, if you will, that occurred during the Chapek era.”

Industry Trends in Fast Casual Dining

7:17 to 12:45

Insights into the fast casual dining industry's challenges and changing consumer behavior.

“When Johann Rall received the letter on Christmas Day 1776, he put it away to read later.”

GLP-1 Drug Market Dynamics

12:56 to 14:02

Discussion on the competitive landscape of GLP-1 drugs and the contrasting performances of Novo Nordisk and Eli Lilly.

“The GLP One craze was started by Eli Lilly and Novo Nordisk, are really the two companies that are associated with this.”

Competitive Landscape of GLP-1 Drugs

14:02 to 16:42

Learn about the market dynamics and challenges facing GLP-1 drug producers like Novo Nordisk and Eli Lilly.

“Those are expiring in major international markets soon, including China, Canada, and Brazil.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:05Disney has their new CEO. Is this time different? Motley Fool Money starts now.

0:21welcome to motley full money i'm travis hoyam joined today by lou whiteman and rachel warren the bob eiger era is officially coming to a close on march 18th lou after josh tomorrow was chosen to be the next ceo dana walden who was in the running to be ceo is going to be promoted to chief creative officer. They both got big contracts along with that. Let's start with Iger. How are we going to look back on his tenure over the last 20 or so years at Disney? Yeah, the two tenures, right? Which is what's kind of funny about it. He's had an incredible career. Let's just say that first. The most recent tenure, he turned streaming around.

0:58Streaming was a$2 billion plus loser back in 2022. It's now a profitable business, a billion dollars in profits. I think he gets a lot of credit for that. Part of that is just maturation, so I don't know how much credit. Here's the thing, though. The stock price really liked his first tenure more than the second. The stock has done nothing. How much of that is him and how much of it is, again, the maturing business and the market's losing faith in that core television business? I don't know how much credit to give him for his accomplishments or how much fault to give him for his failures with the stock market.

1:35I will say this. He was a steady hand at the ship. The question now is, will he become Howard Schultz? Will he actually go away? Will he come back again? There's even rumors he's going to run for president, which again would, I guess, get him off of Disney's case for a while. But we can talk about what this means for Disney afterwards, but we really need for him to either walk away or stay involved. Or just stay on for life. Yeah, yeah, yeah. And the worst scenario is a repeat of last time where he kind of did neither. And that didn't work out well. What is different this time is they apparently had over 100 people on their radar for this job.

2:18I think that's always interesting because there was really only two or three who seemed to be seriously in the running but his tenure is going to end about nine months early from their the contracted end at the end of 2026 and there's a story there right i don't know what it is yeah there's there must be a story well and he's also he's going to be a an advisor but not have a a real role coming into the office which he did have when chapek took over going into the pandemic so yeah it seems like there's definitely a story there always is in these you know palisian tree things. But it does seem a little bit different this time.

2:54Disney knows they have to kick them out the door. One thing on those 100 candidates, Balderdash, there's no way they had 100 candidates. What's the expression in football? They wrote a list with 100 people on it. Right. If you have two quarterbacks, you have no quarterback. If I took that seriously, that they really had 100 people interview, that means they had no clue what they wanted. I'm going to give the benefit of out to the board that maybe they had a list of 100 people, but they didn't really consider 100 people there. To me, that would be more scary than positive. Rachel, we're going to look back on this Eiger tenure, especially the last decade, positively?

3:31I think so. I agree with Lou. I think you have to look at both tenures together. You think of that first one right from 05 to 2020. There was really a series of very transformative acquisitions that formed the company we know today, you think of the acquisitions of Pixar, Marvel, Lucasfilm, you know, this really built that modern Disney content engine that we know. I mean, Iker grew Disney's market cap from about 56 billion to more than 230 billion during that initial run. And then you look in these last few years, you know, he returned in late 2022 to replace Bob Chapek. And really that second stint has been focused on stabilizing the company, right?

4:10You know, so he implements about$5.5 billion in cost cuts, really working to achieve streaming profitability, a lot of challenges that the company has faced during that time, including the Hollywood labor strikes. And so I think that a lot of the last few years has been more about stabilization than some of the growth that investors had come to expect in prior years. One thing I'll note, I mean, Iger is planning to remain senior advisor and board member through the end of 2026 to mentor new leadership. And presumably, Probably that might help the company to avoid some of the mistakes, if you will, that occurred during the Chapek era.

4:44So I think that's something that investors should feel pleased with as they're looking at this transition. I think it's a much better thought out, well-planned, orderly transition than perhaps we saw before. Lou, let's look forward now. We do know that DeMauro is coming from the parks. Chapek, by the way, also came from the parks, which that was one thing that I noticed when I went, ah, we already tried this once. Do we really want to do this again? But it does seem, you're right, it does seem like the linear business and the streaming business at least sort of makes sense now. Back in 2019, 2020, Disney Plus was a rocket ship, but they obviously overbuilt.

5:26You had all this confusion during the pandemic. But now we know that, look, the parks is the core of the business. Now the question is what happens to the rest of the business? What happens to these linear networks? In particular, what happens to ESPN? Where do you think Disney goes from here? Yeah, so here's a bold prediction. I can't imagine Disney without the studio. So I'm not going to go as far as like, you know, a total spinoff. Which studio? All the Disney studios? Movie production, because there's so much tie-in. I mean, maybe they just do it with alliances. But some form of a media spinoff.

5:58I think definitely ESPN, maybe Hulu and ABC. You know, we've talked a lot about what's going on with Warner Brothers Discovery about the limited number of chess pieces. I think there's more chess pieces than we know. I think the Disney of the future is going to be somehow more streamlined. We talked about the stock. Stock has done nothing for years with all of these great assets. And it really feels like, whether we're talking about GE, whether we're talking about so many of these companies, that it's time to wonder, is the sum of the parts trailing the valuation of the whole, Maybe they do go with everything and just form some sort of perpetual marketing agreements so they can use the IP of the studios in the parks.

6:41But I really think that there's going to be some sort of a spin out of media or some sort of a separation of Disney. I'm going to say we're going to hear something about this in the next couple of years, but definitely in the next five years. Yeah. If we look back on the early Bob Iger tenure, a lot of those big moves that he made buying Pixar, buying Marvel was done in the first couple of years. I think Pixar, it sounds like he made that call to Steve Jobs basically as soon as he got the job. So the wheels were spinning there. It will be interesting to see what tomorrow does. When we come back, we are going to talk about Chipotle and why people are eating out less.

7:16You're listening to Motley Fool Money.

7:21When Johann Rall received the letter on Christmas Day 1776, he put it away to read later. Maybe he thought it was a season's greeting and wanted to save it for the fireside. But what it actually was, was a warning, delivered to the Hessian colonel, letting him know that General George Washington was crossing the Delaware and would soon attack his forces. The next day, when Raw lost the Battle of Trenton and died from two colonial Boxing Day musket balls, the letter was found, unopened, in his vest pocket. As someone with 15 ,000 unread emails in his inbox, I feel like there's a lesson there. Oh well, this is The Constant, a history of getting things wrong.

8:01I'm Mark Chrysler. Every episode, we look at the bad ideas, mistakes, and accidents that misshaped our world. Find us at ConstantPodcast.com or wherever you get your podcasts. podcasts.

8:20Welcome back to Motley Fool Money. Chipotle's results were reported last night, and they left a lot to be desired in a lot of ways. Rachel, what should we take from this quarter at Chipotle? We had a lot of negative comps, but this seems like a theme with a lot of restaurant stocks right now. Yeah, there's certainly a theme that we're seeing with a lot of these fast casual chains. So for Chipotle transactions in Q4 dropped by about 3.2%. And this is as we're seeing consumers, particularly those in the 25 to 35 age group, that's really a core cohort for Chipotle, as well as those earning under 100K annually.

8:56Those are people that are really pulling back on discretionary spending. So operating margins actually fell a bit compared to a year ago, down to 14.1%. We're also in a time where rising beef, avocado and labor costs that the company's chosen not to fully offset or impacting margins there. They slightly beat on earnings per share. They were marginally ahead of the consensus estimates for revenue. That was up about 5 % year over year. They're still growing aggressively. They opened about 132 new restaurants in Q4 alone. They're looking to open up to 370 new locations in 2026. A few things that I think we should note, kind of looking at this space.

9:32I mean, Chipotle is dealing with issues that some of its rivals are as well. Sweetgreen, Cava are a few that come to mind. We're seeing a shift in how consumers are approaching restaurant spending. We're seeing some of these sit-down chains. Think of Darden restaurants. They own Olive Garden, Texas Roadhouse are gaining market share. I think consumers are becoming increasingly picky about where they're going to put their money to work. Sometimes they're prioritizing those sit-down experiences. At the same time, McDonald's has been actually holding pretty steady in terms of their growth. Taco Bell has been a standout performer within Yum!

10:06Brands. Starbucks is even showing some improvements. So, systematic challenges in the industry at large. Chipotle, I think, is dealing with more broader industry headwinds than company-specific issues, but I would not expect this to resolve in the next few quarters. Lou, one of the things I'm looking at with restaurant stocks is how many times did they mention GLP-1s? In Chipotle's call, they mentioned it twice, and it was actually in relation to their new protein bowl, bowl of chicken, for$3.80. Yeah, they invented the nugget yeah it's the the new version of the nugget slightly healthier than a nugget make maybe but it is interesting that that seemed to be their answer not only to glp ones but also people spending less saying hey if you just want to spend four bucks on some chicken come here yeah it's a weird time because rachel's right some of this does seem to be just maybe stress on the consumer i think it kind of makes sense that if the consumer is stressed they still do plan night outs or special occasion and you still on the fly, but that middle ground where you could go home and cook or save a little money, but you know, you may just get carry out or something that that fast casual is what's suffering.

11:14I do wonder though. I mean, that implies it's short term. I do wonder if some of this is, is we're just so saturated. We've talked about this before. This category didn't exist when I was growing up. It is, you know, from scratch and it has been nothing but growth. Maybe we've reached the natural limit to this market and we have a lot of competitors here. Maybe this speaks to a longer-term problem. What I do know, fourth straight quarter of traffic declines. The good news is they are forecasting flat same-store sales in 2026, which would be better than down. Down in 2025, Travis, last time they were down was the E.

11:54coli scandal a decade ago. Which, by the way, was a great buying opportunity. It was that time because they were young. Here's my question. I mean, they're talking about growth overseas. That's the big thing. Maybe Middle East wants this, Singapore, South Korea, and yes, Mexico. I don't know if that's going to be the path forward the way from say 2016 to 2025, things improve. You're still paying 30 times forward earnings for a mature business, period. Okay. And, you know, I'd rather get a burrito bowl right now from them than get a share of the stock. I like the company. I just, the growth phase is over.

12:35What are you left with? It will be very interesting to see what happens not only with Chipotle, but with restaurants in general. We'll have another few earnings reports coming out in the next few weeks. And GLP-1s are going to be a topic. And speaking of those GLP-1s, they're not all great for even the pharmaceutical companies. We'll get to that in a moment. You're listening to Motley Fool Money. Welcome back to Motley Fool Money. The GLP One craze was started by Eli Lilly and Novo Nordisk, are really the two companies that are associated with this. But Rachel, Novo Nordisk took a huge hit in the market and they're actually expecting a decline in the business.

13:13What is the story behind this? It seems like GLP One should be just growing forever, but it seems like the competitive dynamics are really changing there. Yeah, this is really a tale of two very different businesses. I mean, you think about Novo Nordisk, they had a much kind of slower growing insulin business before they joined the boom from their GLP-1 success. Eli Lilly had a much more kind of established, broader, diverse range of products that they were selling and a much more profitable foundation from which to launch into that growth. And we are seeing a real disparity in how these two companies are performing.

13:45So Novo Nordisk, they're targeting anywhere from a 5 % to 13 % decline in sales and profits for 2026. They've said that the most favored nation pricing deal they reached with the Trump administration has been impactful here. But there's a lot of factors here as well. You've got key patents for semaglutide. That's the active ingredient in Ozempic and Wigofi. Those are expiring in major international markets soon, including China, Canada, and Brazil. There's, of course, the loss of market share to key rivals like Eli Lilly, but also some of the cheaper copycat, if you will, compounded versions of its drugs.

14:17The CEO is saying this is going to be a very challenging year. So all of that does not bode particularly well for the company. Now contrast that, you've got Eli Lilly. They had record results. They're looking for their full year revenue to rise as much as 25 % in 2026. Meanwhile, even as Novo Nordisk, they launched their oral semaglutide. Eli Lilly is looking for approval for their next generation weight loss pill in mid-2026. That's broadly expected to really cannibalize a lot of the sales in the market. They had a 43 % revenue increase in Q4 alone. They saw sales of their key GLP-1 drugs both jump by more than 100%.

14:56Eli Lilly became the first pharma company to surpass a$1 trillion market cap in 2025. Yes, there are some industry-specific challenges, but I think the issues that Novo Nordisk is facing are much more specific to that business.

15:14Yeah. It's a terrible joke here. Who knew that GLP-1s were slimming for Novo Nordisk? But does anyone not have a GLP-1 at this point? It feels like Rachel said. Yeah, and there's more coming to the market over the next couple of years, too. Pricing headwinds in an increasingly competitive market, how many times was that said? You talk about the restaurant stocks, how often was GLP-1 set in their calls? How often was just pricing headwinds set in the Norvo? The Oral was supposed to be the solution here. But if you look at it, it's 2.4 milligrams versus 25 milligrams for the oral. That's 10x the amount of active ingredient.

15:52I'm curious, we're seeing margins fall. How much of that is just startup here and how much of that is somewhat permanent if they do, quote unquote, succeed in moving people to the oral version? What does that do to profitability? That seems like a slippery slope as far as that being the answer. I don't know if Novo has a good answer right here. And as you say, it's only going to get more competitive from here. I get the market's reaction. Again, another thing that is going to be fascinating to follow, because this has been a huge growth story for a number of different companies and a lot of speculation behind some of the new GOP ones that are coming.

16:28But yeah, like Lou said, if you're coming into a very competitive market, maybe it's not the best to be those producers which are having margin pressure, even if you have higher volume. As always, people on the program may have interest in the stocks they talk about in The Motley Fool may have formal recommendations for or against, so don't buy or sell stocks based solely on what you hear. All personal finance content follows The Motley Fool's editorial standards and is not approved by advertisers. Advertisements are sponsored content and provided for informational purposes only. To see our full advertising disclosure, please check out our show notes.

16:59For Lou Whiteman, Rachel Warren, Dan Boyd, and Christy Waterworth behind the glass, I'm Travis William. We'll see you here tomorrow.

17:12Thank you.

From the publisher

Disney has hired a new CEO with Josh D’Amaro taking over for Bob Iger in March. We discuss Iger’s legacy, where D’Amaro will take Disney, and why the company may be setup for success. Then, we cover Chipotle’s earnings and the latest in GLP-1s.Travis Hoium, Lou Whiteman, and Rachel Warren discuss:- Disney’s new CEO- Bob Iger’s legacy- Chipotle’s declining results- The Big Pharma GLP-1 battleCompanies discussed: Novo Nordisk (NOVO), Eli Lilly (LLY), Disney (DIS), Chipotle (CMG).Host: Travis HoiumGuests: Lou Whiteman, Rachel WarrenEngineer: Dan Boyd, Kristi Waterworth

Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement.

We’re committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode.

Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices

More from Motley Fool Hidden Gems Investing

All 453 episodes
Disney Has Its CEOMotley Fool Hidden Gems Investing · 18 min
Listen in VO